Your browser doesn't support javascript.
loading
Study on genotypic resistance mutations to antiretroviral drugs on HIV strains of treated and treatment-naive HIV-1 infectious patients in Hubei province / 中华流行病学杂志
Chinese Journal of Epidemiology ; (12): 1112-1115, 2007.
Article em Zh | WPRIM | ID: wpr-322880
Biblioteca responsável: WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To study the drug resistance status on HIV-1 patients who had been treated with highly active antiretroviral therapy (HAART) and those treatment-naive ones in Hubei province.</p><p><b>METHODS</b>Nested polymerase chain reaction (PCR) was used to amplify 2 kb DNA fragment in HIV pol gene from peripheral blood of the HIV infected patients and the PCR products were sequenced. The sequences were compared to the Stanford HIV drug resistance database.</p><p><b>RESULTS</b>Nineteen patients were treated with regimens composed of two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and one Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI), with 25 patients as treatment-naive. Some protease (PR) drug-resistant mutations were found in these samples, such as D30N (2.27%), D30G (2.27%), M46I (4.55%), M46N (2.27%), I47V (4.55%), I84V (4.55%), I84L (2.27%), N88S (2.27%) and L90S (2.27%) that all belonged to major drug-resistant but A71T (29.55%) belonged to minor resistance mutations Five treated patients were detected having mutations associated RT drug resistance: M41L (5.26%), A62V (5.26%),D67N (5.26%), L210W (5.26%), T215Y (15.79%); K103E (5.26%), K103N (10.53%), Y181C (5.26%), G190A (5.26%), K238N (5.26%), while five treatment-naive patients were detected to have had mutations associated RT drug resistance M184V (4%), K65N (4%), Y115M (4%), F116L (4%), M184I (4%), V179D (4%), G190R (4%).Some additional mutations were detected in RT whose role involve in drug resistance still remained unknown. F214L was positively associated with HAART treatment (P = 0.03).</p><p><b>CONCLUSION</b>Significant differences were found between drug resistance mutations to RTIs in treated and treat-naive patients in Hubei province,indicating that drugs had affected the occurrence of drug resistance mutations. At the same time, novel RT mutations F214L might be associated with HAART or some other drugs.</p>
Assuntos
Texto completo: 1 Base de dados: WPRIM Assunto principal: Infecções por HIV / China / HIV-1 / Inibidores da Transcriptase Reversa / Terapia Antirretroviral de Alta Atividade / Farmacorresistência Viral / Usos Terapêuticos / Tratamento Farmacológico / Genética / Genótipo Limite: Humans País como assunto: Asia Idioma: Zh Ano de publicação: 2007 Tipo de documento: Article
Texto completo: 1 Base de dados: WPRIM Assunto principal: Infecções por HIV / China / HIV-1 / Inibidores da Transcriptase Reversa / Terapia Antirretroviral de Alta Atividade / Farmacorresistência Viral / Usos Terapêuticos / Tratamento Farmacológico / Genética / Genótipo Limite: Humans País como assunto: Asia Idioma: Zh Ano de publicação: 2007 Tipo de documento: Article